Harness Therapeutics Ltd
2 known investors
Harness Therapeutics develops precision therapies for neurodegenerative diseases including Huntington's, Parkinson's, Alzheimer's, and ALS through its proprietary protein modulation platform. The company targets disease modification in hard-to-treat CNS conditions using RNA biology and novel therapeutic approaches.